09.15.20 -- How 'Tumor On A Chip' Can Transform Drug Development
Join this live discussion on the biopharma trends impacting your facility and business. BioPlan Associates’ Eric Langer will join FUJIFILM Diosynth Biotechnologies' Jonathan M. Haigh, Ph.D. and BioProcess Online’s Matt Pillar for an analysis of current events and Q&A on development opportunities, hiring trends, new technology adoption, COVID-19, and more. Register.
This presentation highlights how innovative protein analysis technologies have been adopted for better comparability, release testing, and impurity monitoring, to improve characterization and productivity.
Sutro Biopharma’s CTO, Dr. Shabbir Anik, has contributed to 15 INDs and 10 NDA’s, making him a great choice to sit down for a chat with Business Of Biotech about the mechanics of GMP and CMC strategy in emerging biopharma enterprises. Listen now and subscribe so you never miss an episode.